Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Cost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Harmony Biosciences Holdings (HRMY) Cost of Revenue (2019 - 2025)

Harmony Biosciences Holdings (HRMY) has disclosed Cost of Revenue for 7 consecutive years, with -$10.3 million as the latest value for Q4 2025.

  • Quarterly Cost of Revenue fell 220.86% to -$10.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $80.0 million through Dec 2025, down 13.06% year-over-year, with the annual reading at $119.5 million for FY2025, 7.75% up from the prior year.
  • Cost of Revenue hit -$10.3 million in Q4 2025 for Harmony Biosciences Holdings, down from $29.5 million in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $43.2 million in Q4 2023 to a low of -$10.3 million in Q4 2025.
  • Historically, Cost of Revenue has averaged $22.7 million across 5 years, with a median of $23.6 million in 2023.
  • Biggest five-year swings in Cost of Revenue: surged 388.07% in 2021 and later tumbled 220.86% in 2025.
  • Year by year, Cost of Revenue stood at $30.4 million in 2021, then plummeted by 30.71% to $21.1 million in 2022, then surged by 104.75% to $43.2 million in 2023, then crashed by 80.28% to $8.5 million in 2024, then crashed by 220.86% to -$10.3 million in 2025.
  • Business Quant data shows Cost of Revenue for HRMY at -$10.3 million in Q4 2025, $29.5 million in Q3 2025, and $30.1 million in Q2 2025.